The Tribunal issued a Notice of Hearing on October 16, 2025 setting the matter down to be heard on October 27, 2025 at 10:00 a.m. or as soon thereafter as the hearing can be held in the above-named matter. A copy of the Notice of Hearing dated October 16, 2025 and Application for Enforcement Proceeding […]
Consolidated Edison, Inc. (Con Edison) (NYSE: ED) declared a quarterly dividend of 85 cents a share on its common stock, payable December 15, 2025 to stockholders of record as of November 19, 2025. Consolidated Edison, Inc. is a holding company that provides a wide range of energy-related products and services to its customers through the
(NASDAQ:SWKS), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Skyworks (SWKS) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Skyworks between from August 8, 2023 to February 5, 2025 and would like to discuss your legal rights, call Bragar Eagel &
SKYWORKS REMINDER: Bragar Eagel & Squire, P.C. is Reminds Long-Term Skyworks Solutions, Inc. Stockholders and to Contact the Firm Regarding Ongoing Investigation GlobeNewswire October 16, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Skyworks (SWKS) To Contact Him Directly To Discuss Their Options If you purchased or
Southwest Airlines Co. (NYSE: LUV) invites you to listen to a live webcast of its third quarter 2025 financial results. Details are as follows: When: Thursday, October 23, 2025, at 10:00 AM Eastern TimeWho: Bob Jordan, President, Chief Executive Officer, and Vice Chairman of the Board of Directors AndrewWatterson, Chief Operating Officer TomDoxey, Executive Vice
(NasdaqGM:LFMD), SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) — A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New
(NasdaqGM:LXEO), NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO) (the “Lexeo”), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that it has commenced an underwritten public offering and concurrent private placement of shares of its common stock and, in lieu of common
Elanco Animal Health, Inc. (NYSE: ELAN) will host an Investor Day on Tuesday, December 9, 2025, from approximately 9 a.m. to 12 p.m. Eastern Time in New York City. The event will feature presentations from Elanco's senior leadership team on the company's strategic priorities, financial outlook, and innovation pipeline – defining Elanco's new era of
LFMD 11-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements — Hagens Berman LFMD Investors with Losses Encouraged to Contact the Firm Before Oct. 27th Deadline GlobeNewswire October 16, 2025 SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) — A new federal securities fraud class action lawsuit has been filed against LifeMD
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants GlobeNewswire October 16, 2025 NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO) (the “Lexeo”), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that it has commenced an underwritten public offering and